SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-022573
Filing Date
2020-08-17
Accepted
2020-08-17 16:26:04
Documents
1
Period of Report
2020-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4740
  Complete submission text file 0000899243-20-022573.txt   6154
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XERIS PHARMACEUTICALS 180 N. LASALLE STREET, SUITE 1800 CHICAGO IL 60601
Business Address
PRESTRELSKI STEVEN (Reporting) CIK: 0001744027 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 201110450